Increased treatment options and improved survival in real-world patients with HER2-positive advanced gastric cancer from 2011 to 2023

Keitaro Shimozaki, Akira Ooki, Kaoru Yoshikawa, Koichiro Yoshino, Shohei Udagawa, Hiroki Osumi, Shota Fukuoka, Takeru Wakatsuki, Mariko Ogura, Daisuke Takahari, Eiji Shinozaki, Keisho Chin, Kensei Yamaguchi

Therapeutic Advances in Gastroenterology

Published online on April 11, 2026

Abstract

Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.
Background:Although the emergence of multiple therapeutic agents has benefited patients with human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (AGC), chronological improvements in treatment outcomes for real-world patients ...